Re: Robert J. van Soest, Ellen S. de Morrée, Charlotte F. Kweldam, et al. Targeting the Androgen Receptor Confers in Vivo Cross-resistance between Enzalutamide and Docetaxel, but Not Cabazitaxel, in Castration-resistant Prostate Cancer. Eur Urol 2015;67:981-5

Masaki Shiota, Akira Yokomizo

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)e41-e42
JournalEuropean Urology
Issue number3
Publication statusPublished - Mar 1 2016

All Science Journal Classification (ASJC) codes

  • Urology

Cite this